$1.72
7.50% today
NYSE, Aug 22, 10:11 pm CET
ISIN
US2560861096
Symbol
DCGO

DocGo Stock price

$1.72
+0.26 17.81% 1M
-2.72 61.26% 6M
-2.52 59.43% YTD
-1.74 50.29% 1Y
-8.47 83.12% 3Y
-8.58 83.30% 5Y
-8.58 83.30% 10Y
-8.58 83.30% 20Y
NYSE, Closing price Fri, Aug 22 2025
+0.12 7.50%
ISIN
US2560861096
Symbol
DCGO

Key metrics

Basic
Market capitalization
$156.5m
Enterprise Value
$99.3m
Net debt
positive
Cash
$104.2m
Shares outstanding
97.8m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
0.4 | 0.5
EV/Sales
0.2 | 0.3
EV/FCF
1.2
P/B
0.5
Financial Health
Equity Ratio
70.4%
Return on Equity
6.2%
ROCE
-12.1%
ROIC
-11.7%
Debt/Equity
0.2
Financials (TTM | estimate)
Revenue
$436.0m | $320.8m
EBITDA
$-21.9m | $-25.7m
EBIT
$-37.1m | $-54.0m
Net Income
$-18.3m | $-33.9m
Free Cash Flow
$81.3m
Growth (TTM | estimate)
Revenue
-41.3% | -48.0%
EBITDA
-132.1% | -157.6%
EBIT
-180.0% | -288.3%
Net Income
-160.8% | -269.6%
Free Cash Flow
341.0%
Margin (TTM | estimate)
Gross
33.7%
EBITDA
-5.0% | -8.0%
EBIT
-8.5%
Net
-4.2% | -10.6%
Free Cash Flow
18.7%
More
EPS
$-0.2
FCF per Share
$0.8
Short interest
4.9%
Employees
4k
Rev per Employee
$160.0k
Show more

Is DocGo a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,015 stocks worldwide.

DocGo Stock Analysis

Unlock Scores for Free

Analyst Opinions

13 Analysts have issued a DocGo forecast:

9x Buy
69%
4x Hold
31%

Analyst Opinions

13 Analysts have issued a DocGo forecast:

Buy
69%
Hold
31%

Financial data from DocGo

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
436 436
41% 41%
100%
- Direct Costs 289 289
42% 42%
66%
147 147
40% 40%
34%
- Selling and Administrative Expenses 147 147
12% 12%
34%
- Research and Development Expense 13 13
21% 21%
3%
-22 -22
132% 132%
-5%
- Depreciation and Amortization 15 15
30% 30%
3%
EBIT (Operating Income) EBIT -37 -37
180% 180%
-9%
Net Profit -18 -18
161% 161%
-4%

In millions USD.

Don't miss a Thing! We will send you all news about DocGo directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

DocGo Stock News

Neutral
Business Wire
4 days ago
NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO) (“DocGo”), a leading provider of technology-enabled mobile health and medical transportation services, announced today that management will be participating in the following investor conferences in August and September: Three Part Advisors Midwest (August 26th) Norm Rosenberg, Chief Financial Officer will participate in 1x1 meetings, and deli...
Neutral
Seeking Alpha
14 days ago
DocGo Inc. (NASDAQ:DCGO ) Q2 2025 Earnings Conference Call August 7, 2025 5:00 PM ET Company Participants Lee Bienstock - CEO & Director Mike Cole - Vice President of Investor Relations Norman Rosenberg - Treasurer & CFO Conference Call Participants Aditya Dagaonkar - Unidentified Company Operator Good afternoon, ladies and gentlemen, and welcome to the DocGo Second Quarter Earnings Conference ...
Neutral
The Motley Fool
15 days ago
DocGo (DCGO) Q2 Revenue Falls 51%
More DocGo News

Company Profile

DocGo, Inc. engages in the provision of mobile health services. It operates through the following segments: Transportation Services and Mobile Health Solutions. The Transportation Services segment offers on-demand medical mobility solutions which are marketed under the Ambulnz brand. The Mobile Health Solutions segment includes on-site evaluations, diagnostics, triage, treatment, and medicine administration. The company was founded in 2015 by Stanley Vashovsky and is headquartered in New York, NY.

Head office United States
CEO Bienstock Lee
Employees 3,906
Founded 2015
Website www.docgo.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today